Transactions classified within the Pharmaceuticals sub-sector. Sectors follow a structured hierarchy so filters and comparable sets stay reproducible.
| Target | Buyer / Investor | Sector | Geo | Transaction size | EV / EBITDA |
|---|---|---|---|---|---|
| SimoTech | PerkinElmer | Pharmaceuticals (NEC) | $36.0M – $48.8M | 9× – 12× | |
| Organon | Sun Pharmaceutical Industries Limited | Biopharmaceuticals | $12,000M – $16,200M | 9× – 12× | |
| Entegris’ Life Sciences Fluid Management business | Savillex, Thompson Street Capital Partners | Biopharmaceuticals | $91.0M – $123M | 8× – 11× | |
| AM-Pharma | Ambrose Healthcare | Proprietary & Advanced Pharmaceuticals | $161M | n/m | |
| NewBridge Pharmaceuticals | DKSH | Biopharmaceuticals | $390M | 8× – 11× | |
| Chr. Olesen Synthesis A/S | Samfara LLP | Proprietary & Advanced Pharmaceuticals | $115M – $155M | 10× – 14× | |
| BrevisRefero | Life Science Connect, Latticework Capital | Biopharmaceuticals | $9.3M – $12.6M | 6× – 8× | |
| Recordati | Respighi BidCo, CVC, GBL | Proprietary & Advanced Pharmaceuticals | $72.8M | 12× – 16× | |
| GentleDrop | Mu Medical | Pharmaceuticals (NEC) | $15.3M – $20.7M | n/m | |
| Innovcare | Sun Pharma | Alternative Medicine | $36.4M | 7× – 9× |
Bins are observed deal frequencies across disclosed transactions. Use as a directional reference, not a target valuation.
Use the directory on the recent deals hub to switch between countries, sectors and sub-sectors. A free account unlocks the structured filters that go beyond the public view.